The home healthcare industry is quietly becoming one of the most consequential shifts in modern medicine — moving skilled care out of hospital wards and into living rooms. According to Grand View Research, the global home healthcare market was valued at USD 485.3 billion in 2025 and is projected to climb from USD 504.8 billion in 2026 to USD 1,015.8 billion by 2033, expanding at a CAGR of 10.5% over the forecast period.

That's more than a doubling of market value in under a decade — a trajectory driven by aging populations, ballooning treatment costs, and a technology stack finally mature enough to make remote care safe and reliable. Below, we unpack the segment-level dynamics, the forces fueling this growth, the blind spots operators can't afford to ignore, and how the competitive map is being redrawn.

Analyzing Key Segment Dynamics

By Component: Services still rule, but Equipment is the one to watch The services segment — encompassing skilled nursing, physical/occupational/speech therapy, hospice care, and unskilled home health aide support — commanded a dominant 83.9% revenue share in 2025. This isn't surprising: an aging population needs hands-on, recurring care, not just devices. With the U.S. Census Bureau projecting that all baby boomers will be over 65 by 2030, demand for skilled home health labor is structurally locked in for years.

But the equipment segment — respiratory therapy devices, insulin delivery systems, home dialysis machines, BP and glucose monitors, mobility aids — is forecast to grow at the fastest CAGR of the two. Portable diagnostics are the catalyst here. Amazon India's 2025 at-home diagnostics rollout (60-minute sample collection, 6-hour lab turnaround, built with Orange Health Labs) is a preview of how decentralized testing infrastructure is reshaping the equipment category from "durable medical supply" into a fast-moving consumer-adjacent business.

By Indication: Neurological and mental health disorders lead The neurological & mental disorder segment led all indications with a 16.8% revenue share in 2025, driven by rising prevalence of Alzheimer's, dementia, stroke, and Parkinson's. The Alzheimer's Association reports roughly 6.9 million Americans aged 65+ currently living with the disease — a figure projected to nearly double to 13 million by 2050. Meanwhile, mobility disorders are set to post a robust CAGR of their own, with the CDC noting that 12.2% of U.S. adults report a serious mobility-related disability.

By Region: North America leads, Asia Pacific accelerates North America held 42.3% of global revenue in 2025, underpinned by high disposable income and sophisticated home-care infrastructure. Asia Pacific, however, is the fastest-growing region through 2033 — propelled by underdeveloped hospital infrastructure, expensive inpatient care, and rising chronic disease burden in markets like India, Thailand, and South Korea.

Primary Growth Drivers

1. Telehealth's post-pandemic staying power This isn't a pandemic-era blip. An American Hospital Association article from April 2025 found that roughly 86.9% of U.S. hospitals were offering telehealth services by 2022 — evidence that virtual care infrastructure has become permanent, not provisional.
2. Reimbursement tailwinds Medicare's coverage of home health services — including skilled nursing, physical therapy, and medical social services under Parts A and B, typically at no cost to eligible beneficiaries — has removed one of the biggest historical barriers to adoption. As more payers globally follow suit, the addressable market widens further.
3. Cost-avoidance pressure on health systems Hospital-at-home programs are scaling fast because they're cheaper and reduce readmissions. Cardinal Health's September 2025 expansion of its Velocare at-Home Solutions logistics business — and NHS England's August 2025 expansion of "virtual wards" targeting 40,000+ patients monthly — both illustrate how health systems are treating home care as core infrastructure, not a nice-to-have.
4. Remote patient monitoring maturity Wearables and connected monitoring devices now track vital signs continuously, letting clinicians intervene before a crisis escalates. Philips' July 2025 partnership with Western Australia Health, aimed at improving outcomes and costs through remote monitoring, is a representative example of this driver in action.
5. Rising disposable income in emerging markets Companies are pushing aggressively into historically underpenetrated markets. Apollo Hospital's May 2025 launch of a 90-minute "Doctor on Call" service in Bengaluru, and Aster DM Healthcare's USD 163.9 million, five-year expansion investment across India, both signal that emerging-market demand is being actively cultivated, not just waited on.

Want the full breakdown of segment forecasts, regional data, and company profiles? Download the free sample report to see the complete data behind this analysis.

Market Blind Spots & Challenges

Growth stories rarely mention the friction underneath them — but operators, investors, and payers should be watching a few structural issues closely:

• Fragmented regulation. In the U.S. alone, licensing, training, and certification standards vary by state and province, creating a patchwork compliance burden for any operator trying to scale nationally, let alone globally.
• Workforce bottlenecks. The services segment's dominance depends entirely on a sufficient supply of trained home health aides and skilled nurses. Training and certification programs (like Care Academy's HHA pipeline) help, but labor supply — not demand — may become the binding constraint on growth.
• Uneven reimbursement outside the U.S. Medicare's favorable coverage doesn't translate globally. In many Asia Pacific and Latin American markets, reimbursement frameworks for home-based care are still immature, meaning growth there depends more on out-of-pocket spending and private insurance expansion.
• Interoperability and data fragmentation. As remote monitoring devices, telehealth platforms, and EHRs proliferate, the risk of siloed, non-interoperable data grows — undermining the very care-coordination benefits home healthcare is supposed to deliver.
• Trust and care-quality perception. Especially in newer markets, patients and families need convincing that home-based care matches hospital-grade quality — a perception hurdle that's as important as any technology gap.

Competitive Landscape

The market is highly fragmented, spanning multinational device makers, specialty suppliers, and regional service providers — a structure that rewards both scale and local relationships.

On the supply side, established med-tech and healthcare giants dominate: Medtronic, Abbott, Baxter International, Koninklijke Philips, GE Healthcare, Johnson & Johnson, B. Braun Melsungen, F. Hoffmann-La Roche, Cardinal Health, and Becton, Dickinson, among others, anchor the equipment and consumables side of the market.

On the services side, players like Amedisys, Kindred Healthcare, Genesis Healthcare, Brookdale Senior Living, Home Instead, and Extendicare compete on care quality, geographic density, and payer relationships.

Consolidation is accelerating M&A activity:

• HouseWorks Holdings acquired Rhode Island-based A Caring Experience in March 2026, expanding into New England — with CEO Mike Trigilio framing it as aligning with "founder-led organizations that share our values."
• Baptist Memorial Healthcare completed a USD 55 million acquisition of OCH Regional Medical Center in October 2025.
• CVS Health and Google Cloud announced a strategic partnership in March 2026 to build the Health100 consumer engagement platform, embedding agentic AI into omni-channel healthcare experiences.
• LG and Amwell's Carepoint TV Kit shows how consumer electronics companies are entering the space via healthcare-enabled hardware, not just traditional med-tech channels.

The throughline: whether through geographic acquisitions, technology partnerships, or hardware-software integration, competitive advantage is increasingly about owning the full care pathway — device, data, and delivery — rather than any single piece of it.

The Bottom Line

Home healthcare isn't a niche adjacent to the hospital system anymore — it's becoming a parallel infrastructure layer for how chronic disease, aging, and post-acute recovery get managed. With the market on pace to more than double by 2033, the winners will be the organizations that can solve workforce supply, navigate fragmented regulation, and stitch together interoperable technology — not just the ones riding the demand wave.

Need this research tailored to your market, region, or business unit? Request a customized version of this report — free customization is available with purchase.